Oramed Pharmaceuticals Inc. – Plans of Reorganization, Merger, Acquisition or Similar

NASDAQ: ORMP
Share price (9/30/26): $4.67
Market cap (9/30/26): $194 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-A12B 1 page Oramed Pharmaceuticals Inc. Declares Dividend Distribution of Common Stock Purchase Rights

from 8-K 5 pages Second Amendment to Stock Purchase Agreement

from 10-Q 2 pages First Amendment to Stock Purchase Agreement

from 8-K 42 pages Stock Purchase Agreement Between Oramed Pharmaceuticals Inc. and Sorrento Therapeutics, Inc. August 7, 2023 Stock Purchase Agreement

from 8-K 4 pages Plan of Conversion of Oramed Pharmaceuticals Inc., a Nevada Corporation to Oramed Pharmaceuticals Inc., a Delaware Corporation

from 8-K/A ~10 pages Plan of reorganization, merger, acquisition or similar